With the consolidation of the acquired Heinz portfolio, the consumer products arm of pharma major Cadila Healthcare, Zydus Wellness, is now eyeing a Rs 4,500-crore turnover in the next five years. In fact, analysts feel that the consumer arm will play a crucial role, in terms of contribution to growth at a time when the US and Indian markets have pricing headwinds.
In the March quarter, excluding the Heinz business, the total income of Cadila Healthcare grew 7 per cent, said Deepak Malik, analyst with Edelweiss. The consolidated revenues had grown by 15 per cent year-on-year (YoY) in the fourth